{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:54:06Z","timestamp":1789480446880,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Coronavirus Disease-2019 (COVID-19) vaccination has been associated with the development of carditis, especially in children and adolescent males. However, the rates of these events in the global setting have not been explored in a systematic manner. The aim of this systematic review and meta-analysis is to investigate the rates of carditis in children and adolescents receiving COVID-19 vaccines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PubMed, Embase and several Latin American databases were searched for studies. The number of events, and where available, at-risk populations were extracted. Rate ratios were calculated and expressed as a rate per million doses received. Subgroup analysis based on the dose administered was performed. Subjects\u2009\u2264\u200919\u00a0years old who developed pericarditis or myocarditis following COVID-19 vaccination were included.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 369 entries were retrieved. After screening, 39 articles were included. Our meta-analysis found that 343 patients developed carditis after the administration of 12,602,625 COVID-19 vaccination doses (pooled rate per million: 37.76; 95% confidence interval [CI] 23.57, 59.19). The rate of carditis was higher amongst male patients (pooled rate ratio: 5.04; 95% CI 1.40, 18.19) and after the second vaccination dose (pooled rate ratio: 5.60; 95% CI 1.97, 15.89). In 301 cases of carditis (281 male; mean age: 15.90 (standard deviation [SD] 1.52) years old) reported amongst the case series\/reports, 261 patients were reported to have received treatment. 97.34% of the patients presented with chest pain. The common findings include ST elevation and T wave abnormalities on electrocardiography. Oedema and late gadolinium enhancement in the myocardium were frequently observed in cardiac magnetic resonance imaging (CMR). The mean length of hospital stay was 3.91\u00a0days (SD 1.75). In 298 out of 299 patients (99.67%) the carditis resolved with or without treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Carditis is a rare complication after COVID-19 vaccination across the globe, but the vast majority of episodes are self-limiting with rapid resolution of symptoms within days.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                <jats:p>Central illustration. Balancing the benefits of vaccines on COVID-19-caused carditis and post-vaccination carditis.<\/jats:p>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00392-022-02070-7","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T03:28:47Z","timestamp":1659151727000},"page":"1161-1173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"111","author":[{"given":"Oscar Hou In","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Mui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheuk To","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Ranjithkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endurance","family":"Evbayekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Pay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish Iltaf","family":"Satti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Garcia-Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bazoukis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ksel","family":"\u00c7inier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios S.","family":"Vassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5510-1253","authenticated-orcid":false,"given":"Gary","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Chi Kei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Cardiovascular Analytics Group, the International Health Informatics Study Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar Hou In","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"2070_CR1","unstructured":"World Health Organization (2022) WHO COVID-19 Dashboard. https:\/\/covid19.who.int\/"},{"issue":"4","key":"2070_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJMoa2115481","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews N, Tessier E, Stowe J, Gower C, Kirsebom F, Simmons R et al (2022) Duration of Protection against mild and severe disease by Covid-19 vaccines. N Engl J Med 386(4):340\u2013350. https:\/\/doi.org\/10.1056\/NEJMoa2115481","journal-title":"N Engl J Med"},{"key":"2070_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.15585\/mmwr.mm7020e2","volume":"70","author":"T Pilishvili","year":"2021","unstructured":"Pilishvili T, Fleming-Dutra KE, Farrar JL, Gierke R, Mohr NM, Talan DA et al (2021) Interim estimates of vaccine effectiveness of Pfizer-BioNTech and moderna COVID-19 vaccines among health care personnel-33 U.S. sites, January-March 2021. MMWR Morb Mortal Wkly Rep 70:753\u2013758","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"2070_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","volume":"21","author":"C Menni","year":"2021","unstructured":"Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P et al (2021) Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study. Lancet Infect Dis 21(7):939\u2013949. https:\/\/doi.org\/10.1016\/S1473-3099(21)00224-3","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2070_CR5","first-page":"221","volume":"23","author":"K Xing","year":"2021","unstructured":"Xing K, Tu XY, Liu M, Liang ZW, Chen JN, Li JJ et al (2021) Efficacy and safety of COVID-19 vaccines: a systematic review. Zhongguo Dang Dai Er Ke Za Zhi 23(3):221\u2013228","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"8","key":"2070_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","volume":"70","author":"J Gee","year":"2021","unstructured":"Gee J, Marquez P, Su J, Calvert GM, Liu R, Myers T et al (2021) First month of COVID-19 vaccine safety monitoring-United States, December 14, 2020-January 13, 2021. MMWR Morb Mortal Wkly Rep 70(8):283\u2013288. https:\/\/doi.org\/10.15585\/mmwr.mm7008e3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2070_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijid.2021.12.354","volume":"116","author":"EWW Chan","year":"2022","unstructured":"Chan EWW, Leung MTY, Lau LKW, Leung J, Lum D, Wong RS-M et al (2022) Comparing self-reported reactogenicity between adolescents and adults following the use of BNT162b2 (Pfizer-BioNTech) messenger RNA COVID-19 vaccine: a prospective cohort study. Int J Infect Dis 116:47\u201350","journal-title":"Int J Infect Dis"},{"issue":"1","key":"2070_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/22221751.2022.2050952","volume":"11","author":"FTT Lai","year":"2022","unstructured":"Lai FTT, Chua GT, Chan EWW, Huang L, Kwan MYW, Ma T et al (2022) Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study. Emerg Microbes Infect 11(1):885\u2013893. https:\/\/doi.org\/10.1080\/22221751.2022.2050952","journal-title":"Emerg Microbes Infect"},{"issue":"32","key":"2070_CR9","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.15585\/mmwr.mm7032e4","volume":"70","author":"HG Rosenblum","year":"2021","unstructured":"Rosenblum HG, Hadler SC, Moulia D, Shimabukuro TT, Su JR, Tepper NK et al (2021) Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the advisory committee on immunization practices - United States, July 2021. MMWR Morb Mortal Wkly Rep 70(32):1094\u20131099. https:\/\/doi.org\/10.15585\/mmwr.mm7032e4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2070_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s1473-3099(21)00451-5","volume":"22","author":"EYF Wan","year":"2022","unstructured":"Wan EYF, Chui CSL, Lai FTT, Chan EWY, Li X, Yan VKC et al (2022) Bell\u2019s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis 22(1):64\u201372. https:\/\/doi.org\/10.1016\/s1473-3099(21)00451-5","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"2070_CR11","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jacc.2003.11.053","volume":"43","author":"DC Cassimatis","year":"2004","unstructured":"Cassimatis DC, Atwood JE, Engler RM, Linz PE, Grabenstein JD, Vernalis MN (2004) Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol 43(9):1503\u20131510. https:\/\/doi.org\/10.1016\/j.jacc.2003.11.053","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2070_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4266\/acc.2017.00045","volume":"34","author":"Y-J Kim","year":"2019","unstructured":"Kim Y-J, Bae J-I, Ryoo SM, Kim WY (2019) Acute fulminant myocarditis following influenza vaccination requiring extracorporeal membrane oxygenation. Acute Crit Care 34(2):165\u2013169. https:\/\/doi.org\/10.4266\/acc.2017.00045","journal-title":"Acute Crit Care"},{"issue":"29","key":"2070_CR13","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1016\/j.vaccine.2021.05.087","volume":"39","author":"S Abu Mouch","year":"2021","unstructured":"Abu Mouch S, Roguin A, Hellou E, Ishai A, Shoshan U, Mahamid L et al (2021) Myocarditis following COVID-19 mRNA vaccination. Vaccine 39(29):3790\u20133793. https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.087","journal-title":"Vaccine"},{"issue":"4","key":"2070_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/jama.2021.24110","volume":"327","author":"ME Oster","year":"2022","unstructured":"Oster ME, Shay DK, Su JR, Gee J, Creech CB, Broder KR et al (2022) Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA 327(4):331\u2013340. https:\/\/doi.org\/10.1001\/jama.2021.24110","journal-title":"JAMA"},{"key":"2070_CR15","unstructured":"European Medicines Agency(2021) COVID-19 mRNA Vaccines Comirnaty and Spikevax: risk of myocarditis and pericarditis. Accessed 20 Mar 2022"},{"key":"2070_CR16","unstructured":"US Centers for Disease Control and Prevention (2021) Clinical considerations: myocarditis and pericarditis after receipt of mRNA COVID-19 vaccines among adolescents and young adults. Accessed 23 Mar 2022"},{"key":"2070_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068665","volume":"375","author":"A Husby","year":"2021","unstructured":"Husby A, Hansen JV, Fosbol E, Thiesson EM, Madsen M, Thomsen RW et al (2021) SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study. BMJ 375:e068665. https:\/\/doi.org\/10.1136\/bmj-2021-068665","journal-title":"BMJ"},{"issue":"27","key":"2070_CR18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.15585\/mmwr.mm7027e2","volume":"70","author":"JW Gargano","year":"2021","unstructured":"Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME et al (2021) Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices\u2014United States, June 2021. MMWR Morb Mortal Wkly Rep 70(27):977\u2013982. https:\/\/doi.org\/10.15585\/mmwr.mm7027e2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2070_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41591-021-01630-0","volume":"28","author":"M Patone","year":"2022","unstructured":"Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M et al (2022) Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med 28(2):410\u2013422. https:\/\/doi.org\/10.1038\/s41591-021-01630-0","journal-title":"Nat Med"},{"issue":"2","key":"2070_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41569-021-00662-w","volume":"19","author":"S Heymans","year":"2022","unstructured":"Heymans S, Cooper LT (2022) Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms. Nat Rev Cardiol 19(2):75\u201377. https:\/\/doi.org\/10.1038\/s41569-021-00662-w","journal-title":"Nat Rev Cardiol"},{"key":"2070_CR21","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.13.21267730","author":"OHI Chou","year":"2021","unstructured":"Chou OHI, Zhou J, Lee TTL, Kot T, Lee S, Wai AKC et al (2021) Comparisons of the risk of myopericarditis between COVID-19 patients and individuals receiving COVID-19 vaccines: a population-based study. medRxiv. https:\/\/doi.org\/10.1101\/2021.12.13.21267730","journal-title":"medRxiv"},{"key":"2070_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-022-02007-0","author":"OHI Chou","year":"2022","unstructured":"Chou OHI, Zhou J, Lee TTL, Kot T, Lee S, Wai AKC et al (2022) Comparisons of the risk of myopericarditis between COVID-19 patients and individuals receiving COVID-19 vaccines: a population-based study. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-022-02007-0","journal-title":"Clin Res Cardiol"},{"key":"2070_CR23","doi-asserted-by":"publisher","first-page":"692990","DOI":"10.3389\/fcvm.2021.692990","volume":"8","author":"X Wang","year":"2021","unstructured":"Wang X, Bu X, Wei L, Liu J, Yang D, Mann DL et al (2021) Global, regional, and national burden of myocarditis from 1990 to 2017: a systematic analysis based on the global burden of disease study 2017. Front Cardiovasc Med 8:692990. https:\/\/doi.org\/10.3389\/fcvm.2021.692990","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"2070_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.7453\/gahmj.2013.008","volume":"2","author":"JJ Gagnier","year":"2013","unstructured":"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D (2013) The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med 2(5):38\u201343. https:\/\/doi.org\/10.7453\/gahmj.2013.008","journal-title":"Glob Adv Health Med"},{"key":"2070_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","volume":"89","author":"DS Riley","year":"2017","unstructured":"Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P et al (2017) CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol 89:218\u2013235. https:\/\/doi.org\/10.1016\/j.jclinepi.2017.04.026","journal-title":"J Clin Epidemiol"},{"issue":"15","key":"2070_CR26","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiologya proposal for reporting. JAMA 283(15):2008\u20132012. https:\/\/doi.org\/10.1001\/jama.283.15.2008","journal-title":"JAMA"},{"issue":"5","key":"2070_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R et al (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384(5):403\u2013416. https:\/\/doi.org\/10.1056\/NEJMoa2035389","journal-title":"N Engl J Med"},{"issue":"27","key":"2070_CR28","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383(27):2603\u20132615. https:\/\/doi.org\/10.1056\/NEJMoa2034577","journal-title":"N Engl J Med"},{"key":"2070_CR29","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1016\/j.vaccine.2021.05.016","volume":"39","author":"D Gubernot","year":"2021","unstructured":"Gubernot D, Jazwa A, Niu M, Baumblatt J, Gee J, Moro P et al (2021) U S. population-based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines. Vaccine 39:3666\u20133677. https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.016","journal-title":"Vaccine"},{"issue":"2","key":"2070_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/ehjqcco\/qcab090","volume":"8","author":"D Foltran","year":"2022","unstructured":"Foltran D, Delmas C, Flumian C, De Paoli P, Salvo F, Gautier S et al (2022) Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. Eur Heart J Qual Care Clin Outcomes 8(2):99\u2013103. https:\/\/doi.org\/10.1093\/ehjqcco\/qcab090","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"1","key":"2070_CR31","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1097\/inf.0000000000003389","volume":"41","author":"U Nygaard","year":"2022","unstructured":"Nygaard U, Holm M, Bohnstedt C, Chai Q, Schmidt LS, Hartling UB et al (2022) Population-based incidence of myopericarditis after COVID-19 vaccination in danish adolescents. Pediatr Infect Dis J 41(1):e25\u2013e28. https:\/\/doi.org\/10.1097\/inf.0000000000003389","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"2070_CR32","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamacardio.2021.3471","volume":"6","author":"A Dionne","year":"2021","unstructured":"Dionne A, Sperotto F, Chamberlain S, Baker AL, Powell AJ, Prakash A et al (2021) Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA Cardiol 6(12):1446\u20131450. https:\/\/doi.org\/10.1001\/jamacardio.2021.3471","journal-title":"JAMA Cardiol"},{"issue":"10","key":"2070_CR33","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/jpids\/piab060","volume":"10","author":"E Tano","year":"2021","unstructured":"Tano E, San Martin S, Girgis S, Martinez-Fernandez Y, Sanchez VC (2021) Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. J Pediatric Infect Dis Soc 10(10):962\u2013966. https:\/\/doi.org\/10.1093\/jpids\/piab060","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2070_CR34","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1097\/INF.0000000000003235","volume":"40","author":"O Snapiri","year":"2021","unstructured":"Snapiri O, Rosenberg Danziger C, Shirman N, Weissbach A, Lowenthal A, Ayalon I et al (2021) Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine. Pediatr Infect Dis J 40:e360\u2013e363","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2070_CR35","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2214\/ajr.21.26853","volume":"218","author":"L Chelala","year":"2022","unstructured":"Chelala L, Jeudy J, Hossain R, Rosenthal G, Pietris N, White CS (2022) Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents. AJR Am J Roentgenol 218(4):651\u2013657. https:\/\/doi.org\/10.2214\/ajr.21.26853","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"2070_CR36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","volume":"144","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt B, Kamat I, Hotez PJ (2021) Myocarditis with COVID-19 mRNA vaccines. Circulation 144(6):471\u2013484. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056135","journal-title":"Circulation"},{"issue":"3","key":"2070_CR37","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/cpt.2499","volume":"111","author":"L Chouchana","year":"2022","unstructured":"Chouchana L, Blet A, Al-Khalaf M, Kafil TS, Nair G, Robblee J et al (2022) Features of inflammatory heart reactions following mRNA COVID-19 vaccination at a global level. Clin Pharmacol Ther 111(3):605\u2013613. https:\/\/doi.org\/10.1002\/cpt.2499","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"2070_CR38","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7326\/m21-3700","volume":"175","author":"FTT Lai","year":"2022","unstructured":"Lai FTT, Li X, Peng K, Huang L, Ip P, Tong X et al (2022) Carditis after COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine\u202f: a case-control study. Ann Intern Med 175(3):362\u2013370. https:\/\/doi.org\/10.7326\/m21-3700","journal-title":"Ann Intern Med"},{"key":"2070_CR39","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/eurheartj\/eht309.3505","volume":"34","author":"V Kyto","year":"2013","unstructured":"Kyto V, Sipila J, Rautava P (2013) Gender differences in myocarditis: a nationwide study in Finland. Eur Heart J 34:3505","journal-title":"Eur Heart J"},{"key":"2070_CR40","doi-asserted-by":"publisher","first-page":"5502","DOI":"10.3390\/jcm10235502","volume":"10","author":"K Ozieranski","year":"2021","unstructured":"Ozieranski K, Tyminska A, Skwarek A, Kruk M, Kon B, Bilinski J et al (2021) Sex differences in incidence, clinical characteristics and outcomes in children and young adults hospitalized for clinically suspected myocarditis in the last ten years-data from the MYO-PL nationwide database. J Clin Med 10:5502","journal-title":"J Clin Med"},{"issue":"22","key":"2070_CR41","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/heartjnl-2013-304449","volume":"99","author":"V Kyto","year":"2013","unstructured":"Kyto V, Sipila J, Rautava P (2013) The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood. Heart 99(22):1681\u20131684. https:\/\/doi.org\/10.1136\/heartjnl-2013-304449","journal-title":"Heart"},{"key":"2070_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab989","author":"GT Chua","year":"2021","unstructured":"Chua GT, Kwan MYW, Chui CSL, Smith RD, Cheung EC, Tian T et al (2021) Epidemiology of acute myocarditis\/pericarditis in Hong Kong adolescents following comirnaty vaccination. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciab989","journal-title":"Clin Infect Dis"},{"key":"2070_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.0101","author":"X Li","year":"2022","unstructured":"Li X, Lai FTT, Chua GT, Kwan MYW, Lau YL, Ip P et al (2022) Myocarditis following COVID-19 BNT162b2 Vaccination among adolescents in Hong Kong. JAMA Pediatr. https:\/\/doi.org\/10.1001\/jamapediatrics.2022.0101","journal-title":"JAMA Pediatr"},{"issue":"5","key":"2070_CR44","doi-asserted-by":"publisher","first-page":"326","DOI":"10.12809\/hkmj215120","volume":"27","author":"MYW Kwan","year":"2021","unstructured":"Kwan MYW, Chua GT, Chow CB, Tsao SSL, To KKW, Yuen KY et al (2021) mRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J 27(5):326\u2013327. https:\/\/doi.org\/10.12809\/hkmj215120","journal-title":"Hong Kong Med J"},{"key":"2070_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00631-3","author":"BA Satterfield","year":"2021","unstructured":"Satterfield BA, Bhatt DL, Gersh BJ (2021) Cardiac involvement in the long-term implications of COVID-19. Nat Rev Cardiol. https:\/\/doi.org\/10.1038\/s41569-021-00631-3","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"2070_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102524","volume":"19","author":"F Caso","year":"2020","unstructured":"Caso F, Costa L, Ruscitti P, Navarini L, Del Puente A, Giacomelli R et al (2020) Could Sars-coronavirus-2 trigger autoimmune and\/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun Rev 19(5):102524. https:\/\/doi.org\/10.1016\/j.autrev.2020.102524","journal-title":"Autoimmun Rev"},{"issue":"4","key":"2070_CR47","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/s1388-9842(02)00010-7","volume":"4","author":"AL Caforio","year":"2002","unstructured":"Caforio AL, Mahon NJ, Tona F, McKenna WJ (2002) Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 4(4):411\u2013417. https:\/\/doi.org\/10.1016\/s1388-9842(02)00010-7","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"2070_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13613-020-00690-8","volume":"10","author":"M Grimaud","year":"2020","unstructured":"Grimaud M, Starck J, Levy M, Marais C, Chareyre J, Khraiche D et al (2020) Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care 10(1):69. https:\/\/doi.org\/10.1186\/s13613-020-00690-8","journal-title":"Ann Intensive Care"},{"issue":"11","key":"2070_CR49","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","volume":"5","author":"VO Puntmann","year":"2020","unstructured":"Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J et al (2020) Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 5(11):1265\u20131273. https:\/\/doi.org\/10.1001\/jamacardio.2020.3557","journal-title":"JAMA Cardiol"},{"issue":"7","key":"2070_CR50","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/acem.14307","volume":"28","author":"A Fleming-Nouri","year":"2021","unstructured":"Fleming-Nouri A, Haimovich AD, Yang D, Schulz WL, Coppi A, Taylor RA (2021) Myopericarditis in young adults presenting to the emergency department after receiving a second COVID-19 mRNA vaccine. Acad Emerg Med 28(7):802\u2013805. https:\/\/doi.org\/10.1111\/acem.14307","journal-title":"Acad Emerg Med"},{"key":"2070_CR51","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jpeds.2021.07.044","volume":"238","author":"BB Das","year":"2021","unstructured":"Das BB, Kohli U, Ramachandran P, Nguyen HH, Greil G, Hussain T et al (2021) Myopericarditis after messenger RNA Coronavirus disease 2019 vaccination in adolescents 12 to 18 years of age. J Pediatr 238:26-32.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2021.07.044","journal-title":"J Pediatr"},{"issue":"26","key":"2070_CR52","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMoa2115624","volume":"385","author":"R Arbel","year":"2021","unstructured":"Arbel R, Hammerman A, Sergienko R, Friger M, Peretz A, Netzer D et al (2021) BNT162b2 vaccine booster and mortality due to Covid-19. N Engl J Med 385(26):2413\u20132420. https:\/\/doi.org\/10.1056\/NEJMoa2115624","journal-title":"N Engl J Med"},{"key":"2070_CR53","doi-asserted-by":"publisher","first-page":"e13759","DOI":"10.1111\/eci.13759","volume":"52","author":"A Krug","year":"2022","unstructured":"Krug A, Stevenson J, H\u00f8eg TB (2022) BNT162b2 vaccine-associated myo\/pericarditis in adolescents: a stratified risk-benefit analysis. Eur J Clin Invest 52:e13759. https:\/\/doi.org\/10.1111\/eci.13759","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"2070_CR54","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1080\/21645515.2021.1984132","volume":"17","author":"PL Moro","year":"2021","unstructured":"Moro PL, Panagiotakopoulos L, Oduyebo T, Olson CK, Myers T (2021) Monitoring the safety of COVID-19 vaccines in pregnancy in the US. Hum Vaccin Immunother 17(12):4705\u20134713. https:\/\/doi.org\/10.1080\/21645515.2021.1984132","journal-title":"Hum Vaccin Immunother"},{"key":"2070_CR55","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.02.21267156","author":"SA Buchan","year":"2021","unstructured":"Buchan SA, Seo CY, Johnson C, Alley S, Kwong JC, Nasreen S et al (2021) Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval. MedRxiv. https:\/\/doi.org\/10.1101\/2021.12.02.21267156","journal-title":"MedRxiv"},{"key":"2070_CR56","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.12.22269169","author":"S Nasreen","year":"2022","unstructured":"Nasreen S, Calzavara A, Buchan SA, Thampi N, Johnson C, Wilson SE et al (2022) Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance. MedRxiv. https:\/\/doi.org\/10.1101\/2022.01.12.22269169","journal-title":"MedRxiv"},{"key":"2070_CR57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.amjcard.2021.03.019","volume":"149","author":"R Vasudeva","year":"2021","unstructured":"Vasudeva R, Bhatt P, Lilje C, Desai P, Amponsah J, Umscheid J et al (2021) Trends in acute myocarditis related pediatric hospitalizations in the united states, 2007\u20132016. Am J Cardiol 149:95\u2013102. https:\/\/doi.org\/10.1016\/j.amjcard.2021.03.019","journal-title":"Am J Cardiol"},{"key":"2070_CR58","doi-asserted-by":"publisher","DOI":"10.1101\/2021.07.23.21260998","author":"ME Singer","year":"2021","unstructured":"Singer ME, Taub IB, Kaelber DC (2021) Risk of myocarditis from COVID-19 Infection in people under age 20 a population-based analysis. MedRxiv. https:\/\/doi.org\/10.1101\/2021.07.23.21260998","journal-title":"MedRxiv"},{"issue":"10","key":"2070_CR59","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJMc2116999","volume":"386","author":"D Mevorach","year":"2022","unstructured":"Mevorach D, Anis E, Cedar N, Hasin T, Bromberg M, Goldberg L et al (2022) Myocarditis after BNT162b2 vaccination in Israeli adolescents. N Engl J Med 386(10):998\u2013999. https:\/\/doi.org\/10.1056\/NEJMc2116999","journal-title":"N Engl J Med"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02070-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-022-02070-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02070-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T11:13:05Z","timestamp":1664536385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-022-02070-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["2070"],"URL":"https:\/\/doi.org\/10.1007\/s00392-022-02070-7","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}